Pharmaids [PHARMAID] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Pharmaids

BSE
Loading...

Innova Captab

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Pharmaids wins in 5 metrics, Innova Captab wins in 12 metrics, with 0 ties. Innova Captab appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricPharmaidsInnova CaptabBetter
P/E Ratio (TTM)2,023.3337.44Innova Captab
Price-to-Book Ratio3.355.07Pharmaids
Debt-to-Equity Ratio70.8135.24Innova Captab
PEG Ratio23.667.14Innova Captab
EV/EBITDA-16.2226.94Pharmaids
Profit Margin (TTM)-61.01%9.98%Innova Captab
Operating Margin (TTM)-90.28%11.68%Innova Captab
EBITDA Margin (TTM)N/A11.68%N/A
Return on Equity-19.58%13.37%Innova Captab
Return on Assets (TTM)-8.99%8.12%Innova Captab
Free Cash Flow (TTM)$-264.72M$-1.09BPharmaids
1-Year Return30.67%16.88%Pharmaids
Price-to-Sales Ratio (TTM)9.253.74Innova Captab
Enterprise Value$2.35B$51.37BInnova Captab
EV/Revenue Ratio10.983.95Innova Captab
Gross Profit Margin (TTM)47.39%37.21%Pharmaids
Revenue per Share (TTM)$6$227Innova Captab
Earnings per Share (Diluted)$-3.71$22.70Innova Captab
Beta (Stock Volatility)0.53N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Pharmaids vs Innova Captab Stock Performance Analysis

Loading Price Chart...

Pharmaids
Innova Captab
Pharmaids Stock Overview | Innova Captab Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pharmaids-5.46%-12.16%-14.88%-8.85%-19.65%-29.42%
Innova Captab-0.80%-2.09%-4.29%-1.76%0.12%-24.72%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pharmaids30.67%281.24%550.44%1,134.75%1,482.73%125.13%
Innova Captab16.88%54.27%54.27%54.27%54.27%54.27%

News Based Sentiment: Pharmaids vs Innova Captab

Pharmaids

News based Sentiment: MIXED

September brought substantial changes to Pharmaids Pharmaceuticals, including a major divestiture and an ongoing open offer, alongside continued financial difficulties. These events create both opportunities and risks for investors, making it a significant month for the company's trajectory. The mixed signals from insider trading add to the complexity of the investment picture.

View Pharmaids News Sentiment Analysis

Innova Captab

News based Sentiment: POSITIVE

Innova Captab reported impressive revenue and profit growth for both Q1 FY2026 and the full fiscal year 2025-26, supported by a 'Buy' rating from JM Financial. While there were shifts in shareholding, particularly a decrease in FII holdings, the overall narrative points towards a positive trajectory for the company.

View Innova Captab News Sentiment Analysis

Performance & Financial Health Analysis: Pharmaids vs Innova Captab

MetricPHARMAIDINNOVACAP
Market Information
Market Cap i₹1.98B₹48.64B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i4,98933,824
90 Day Avg. Volume i4,93740,665
Last Close₹49.38₹828.50
52 Week Range₹45.50 - ₹84.97₹662.00 - ₹1,260.00
% from 52W High-41.89%-34.25%
All-Time High₹87.46 (Nov 11, 2024)₹1,260.00 (Jan 06, 2025)
% from All-Time High-43.54%-34.25%
Growth Metrics
Quarterly Revenue Growth0.43%0.20%
Quarterly Earnings Growth0.43%0.05%
Financial Health
Profit Margin (TTM) i-0.61%0.10%
Operating Margin (TTM) i-0.90%0.12%
Return on Equity (TTM) i-0.20%0.13%
Debt to Equity (MRQ) i70.8135.24
Cash & Liquidity
Book Value per Share (MRQ)₹16.72₹167.66
Cash per Share (MRQ)₹0.61₹11.41
Operating Cash Flow (TTM) i₹-278,094,000₹282.88M
Levered Free Cash Flow (TTM) i₹-107,766,000₹1.28B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Pharmaids vs Innova Captab

MetricPHARMAIDINNOVACAP
Price Ratios
P/E Ratio (TTM) i2,023.3337.44
Forward P/E iN/A20.01
PEG Ratio i23.667.14
Price to Sales (TTM) i9.253.74
Price to Book (MRQ) i3.355.07
Market Capitalization
Market Capitalization i₹1.98B₹48.64B
Enterprise Value i₹2.35B₹51.37B
Enterprise Value Metrics
Enterprise to Revenue i10.983.95
Enterprise to EBITDA i-16.2226.94
Risk & Other Metrics
Beta i0.53N/A
Book Value per Share (MRQ) i₹16.72₹167.66

Financial Statements Comparison: Pharmaids vs Innova Captab

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PHARMAIDINNOVACAP
Revenue/Sales i₹66.64M₹3.52B
Cost of Goods Sold i₹35.06M₹2.21B
Gross Profit i₹31.58M₹1.31B
Research & Development iN/AN/A
Operating Income (EBIT) i₹-60.16M₹410.54M
EBITDA i₹-53.69M₹565.82M
Pre-Tax Income i₹-71.71M₹426.77M
Income Tax i₹-18.56M₹116.62M
Net Income (Profit) i₹-53.15M₹310.15M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PHARMAIDINNOVACAP
Cash & Equivalents i₹21.45M₹155.19M
Total Current Assets i₹223.07M₹7.03B
Total Current Liabilities i₹287.15M₹3.53B
Long-Term Debt i₹331.19M₹2.45B
Total Shareholders Equity i₹550.42M₹9.59B
Retained Earnings i₹-266.77M₹4.53B
Property, Plant & Equipment i₹19.32M₹442.93M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PHARMAIDINNOVACAP
Operating Cash Flow i₹-1.10M₹378.60M
Capital Expenditures i₹0₹-1.21B
Free Cash Flow i₹2.39M₹-908.56M
Debt Repayment iN/A₹-7.69M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPHARMAIDINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i4,98933,824
Average Daily Volume (90 Day) i4,93740,665
Shares Outstanding i35.27M57.22M
Float Shares i5.78M15.70M
% Held by Insiders i0.77%0.72%
% Held by Institutions i0.00%0.19%

Dividend Analysis & Yield Comparison: Pharmaids vs Innova Captab

MetricPHARMAIDINNOVACAP
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A